Small Cell Carcinoma of the Prostate

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-07-22
Clinical Trial Update: ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating ZEN-3694 in combination with enzalutamide and pembrolizumab for metastatic castration-resistant …